Related Experiment Videos
Immunizations for pediatric transplant patients
1Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York.
Kidney International. Supplement
|October 1, 1993
Summary
Vaccination is key to preventing infections in transplant patients. Routine and special vaccines, including live-attenuated varicella vaccine, significantly reduce transplant-associated morbidity and mortality.
Area of Science:
- Immunology
- Transplant Medicine
- Infectious Diseases
Background:
- Infection is a primary cause of death and illness in transplant recipients.
- Immunization strategies are crucial for preventing infections in this vulnerable population.
Purpose of the Study:
- To review the application of routine pediatric vaccines (diphtheria-pertussis-tetanus, measles-mumps-rubella) in transplant patients.
- To discuss the use of specialized vaccines (hepatitis B, pneumococcal, influenza) in transplant recipients.
- To evaluate experimental live-attenuated virus vaccines for cytomegalovirus and varicella.
Main Methods:
- Review of existing literature and data on vaccine use in transplant patients.
- Analysis of safety and efficacy data for various vaccines, including live-attenuated viral vaccines.
Main Results:
- Routine pediatric vaccines (diphtheria-pertussis-tetanus, measles-mumps-rubella) present unique challenges in transplant patients.
- Specialized vaccines like hepatitis B, pneumococcal, and influenza are important for this group.
- Live-attenuated varicella vaccine shows promise in preventing varicella-zoster virus infection, with successful administration in immunocompromised children.
Conclusions:
- Immunization is a critical preventive measure against infections in transplant patients.
- Live-attenuated varicella vaccine is highly effective and recommended for preventing varicella-zoster virus infection in transplant recipients.